Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-28T03:54:06.087Z Has data issue: false hasContentIssue false
  • English
  • Français

Nortriptyline Therapy in Elderly Patients: Dosage Prediction from Plasma Concentration at 24 Hours after a Single 50 mg Dose

Published online by Cambridge University Press:  29 January 2018

S. Dawling ,
P. Crome ,
E. J. Heyer  and
R. R. Lewis
S. Dawling
Affiliation:
Poisons Unit, Guy's Hospital, London SE1 9RT
P. Crome
Affiliation:
Guy's Department of Geriatric and General Medicine
E. J. Heyer
Affiliation:
Guy's Department of Geriatric and General Medicine
R. R. Lewis
Affiliation:
Guy's Department of Geriatric and General Medicine New Cross Hospital, Avonley Road, London SE14 5ER
Get access Rights & Permissions [Opens in a new window]

Summary

Ten depressed elderly female patients in hospital (mean age 82 years) received a single oral dose of 50 mg nortriptyline prior to commencing treatment with this drug. The nortriptyline concentration in a plasma sample obtained 24 hours afterwards was used to predict the daily dose required to achieve a steady-state concentration within the range of 50–150 μg.l-1. The mean daily dose prescribed was 50 mg (range 20–100 mg). These dosage regimes provided a mean observed steady-state nortriptyline concentration of 104 μg.l-1, with a range of 76–180 μg.l-1 (S.D. 30 μg.l-1). Use of this prediction test can prevent the development of toxic plasma concentrations and enhance the possibility of therapeutic success.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 139 , Issue 5 , November 1981 , pp. 413 - 416
Copyright
Copyright © Royal College of Psychiatrists, 1981 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aherne, G. W., Piall, E. M. & Marks, V. (1976) The radioimmunoassay of tricyclic antidepressants. British Journal of Clinical Pharmacology, 3, 561–5.CrossRefGoogle ScholarPubMed
Alexanderson, B. (1972) Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data. European Journal of Clinical Pharmacology, 4, 82—91.CrossRefGoogle ScholarPubMed
Alexanderson, B. (1973) Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins. European Journal of Clinical Pharmacology, 6, 44—53.CrossRefGoogle ScholarPubMed
Åsberg, M. (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. British Medical Journal, iv, 18—21.CrossRefGoogle Scholar
Åsberg, M. (1978) Treatment of depression with tricyclic drugs—pharmacokinetic and pharmacodynamic aspects. Pharmakopsychiatrie Neuro-Psychopharmakologie, 9, 18—26.CrossRefGoogle Scholar
Åsberg, M., Cronholm, B., Sjöqvist, F. & Tuck, R. (1971) Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, iii, 331–4.Google Scholar
Braithwaite, R., Montgomery, S. & Dawung, S. (1978) Nortriptyline in depressed patients with high plasma levels. Clinical Pharmacology and Therapeutics, 23, 303–8.CrossRefGoogle ScholarPubMed
Brunswick, D. J., Amsterdam, J. D., Mendels, J. & Stern, S. L. (1979) Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data. Clinical Pharmacology and Therapeutics, 25, 605–10.CrossRefGoogle ScholarPubMed
Burrows, G. D., Vohra, J., Hunt, D., Sloman, J. G., Scoggins, B. A. & Davies, B. (1976) Cardiac effects of different tricyclic antidepressant drugs. British Journal of Psychiatry, 129, 335–41.CrossRefGoogle ScholarPubMed
Cooper, T. B. & Simpson, G. M. (1978) Prediction of individual dosage of nortriptyline. American Journal of Psychiatry, 135, 330–5.Google ScholarPubMed
Dawling, S. & Braithwaite, R. (1978) Simplified method for monitoring tricyclic antidepressant therapy using gas-liquid chromatography with nitrogen detection. Journal of Chromatography, 146, 449–56.CrossRefGoogle ScholarPubMed
Dawling, S., Crome, P., Braithwaite, R. A. & Lewis, R. R. (1980) Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study. European Journal of Clinical Pharmacology, 18, 147–50.CrossRefGoogle ScholarPubMed
Kragh-Sørensen, P., Eggert-Hansen, G., Baastrup, P. C. & Hvidberg, E. F. (1976) Self inhibiting action of nortriptylin's antidepressive effect at high plasma levels. Psychopharmacologia (Berl.), 45, 305–12.CrossRefGoogle ScholarPubMed
Learoyd, B. M. (1972) Psychotropic drugs and the elderly patient. Medical Journal of Australia, i, 1131–3.Google Scholar
Montgomery, S., Braithwaite, R., Dawling, S. & McAuley, R. (1978) High plasma nortriptyline levels in the treatment of depression. Clinical Pharmacology and Therapeutics, 23, 309–14.CrossRefGoogle ScholarPubMed
Potter, W. Z., Zavadil, A. P., Kopin, I. J. & Goodwin, F. K. (1980) Single-dose kinetics predict steady-state concentrations of imipramine and desipramine. Archives of General Psychiatry, 37, 314–20.CrossRefGoogle ScholarPubMed
Ziegler, V. E., Clayton, P. J., Taylor, J. R., Co, B. T. & Biggs, J. T. (1976) Nortriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics, 20, 458–63.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.